Depletion of 14-3-3ζ has been found to induce the apoptosis of CRC cells in vitro and in vivo [18], suggesting that identifying or developing novel inhbitors of 14-3-3ζ that disrupt interactions with BAD may represent a promising approach towards the treatment of CRC and other cancers. This evidence concerns the gene BAD and cancer.